Sort
35,931 grants matching “parkinsons”
Neuroprotection and early detection in PD
$1,233,642Michael J Zigmond · University Of Pittsburgh At Pittsburgh · P50 · FY2007 · NS
Stimulus-evoked directional field potentials to guide subthalamic and pallidal DBS for PD
$1,232,410Harrison Carroll Walker · University Of Alabama At Birmingham · UG3 · FY2024 · NS
HCC: Medium: Automatic detection of atypical patterns in cross-modal affect
$1,232,000Jan P Van Santen · Oregon Health & Science University · · FY2009 · CSE
Functional Organization Of The Cerebral Cortex and Basal Ganglia
$1,231,811Charles R Gerfen · National Institute Of Mental Health · ZIA · FY2014 · MH
EXPERIENCE-DEPENDENT STRUCTURAL PLASTICITY IN CNS
$1,230,253University Of Texas San Antonio · U54 · FY2000 · NS
Spatial-Temporal Characterization of The Hemodynamic Response to Neural Activity
$1,229,931Afonso Silva · National Institute Of Neurological Disorders And Stroke · ZIA · FY2011 · NS
GM1 Ganglioside Effects on Parkinson's Disease
$1,229,870Thomas Jefferson University · R01 · FY2005 · NS
EXPERIENCE-DEPENDENT STRUCTURAL PLASTICITY IN CNS
$1,229,414University Of Texas San Antonio · U54 · FY2003 · NS
Treating Agitation/Psychosis in Dementia/Parkinsonism
$1,229,242University Of Rochester · R01 · FY2002 · AG
Molecular Engineering of Natural Light-Gated Chloride Channels for Optogenetic Inhibition
$1,228,600Mingshan Xue · Baylor College Of Medicine · U01 · FY2021 · NS
Molecular Roles of Cdk5 in Neuronal Functions and Pain Signaling
$1,227,941Ashok Kulkarni · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE
Phase 3 trial of inosine for Parkinson's disease - DCC
$1,227,432David Oakes · University Of Rochester · U01 · FY2016 · NS
Vascular contribution to white matter lesions and motor dysfunction in AD and ADRD
$1,226,883Hyung Jin Ahn · Rutgers Biomedical And Health Sciences · RF1 · FY2025 · AG
Early Events in Alzheimer Pathogenesis
$1,226,455Sue T Griffin · Univ Of Arkansas For Med Scis · P01 · FY2012 · AG
Improving neural graft function in parkinsonian monkeys.
$1,226,266Yale University · P01 · FY2003 · NS
Mitochrondrial Etiologies of Parkinsons Disease
$1,225,850James Pepper Bennett · University Of Virginia · P50 · FY2009 · NS
TAUOPATHIES: GENOTYPE AND PHENOTYPE
$1,225,672University Of Pennsylvania · P01 · FY2001 · AG
Neuroprotective role of GLP-1 receptor agonists (Neurodegenerative disorders & Alzheimer's disease)
$1,225,528Nigel H. Greig · National Institute On Aging · ZIA · FY2023 · AG
Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia
$1,225,098Judith Richmon Walters · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
EXPERIENCE-DEPENDENT STRUCTURAL PLASTICITY IN CNS
$1,224,874University Of Texas San Antonio · U54 · FY2002 · NS
The regulation of synaptic transmission and neural circuit function
$1,224,004Wei Lu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Mitochondrial Proteins in Parkinson's Disease
$1,223,987J Timothy Greenamyre · University Of Pittsburgh At Pittsburgh · P01 · FY2013 · NS
Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic
$1,223,655Clive Niels Svendsen · Cedars-Sinai Medical Center · UG3 · FY2017 · NS
Dissecting Oligogenic Biomarkers in Ashkenazi Jews with Parkinson Disease
$1,222,953Rachel Saunders-Pullman · Icahn School Of Medicine At Mount Sinai · U01 · FY2022 · NS
Rhythmicity and Synchrony in the Basal Ganglia
$1,222,179Dalton James Surmeier · Northwestern University At Chicago · P50 · FY2009 · NS